Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort

(2010) Samuel K. Shinjo et al.   ARTHRITIS AND RHEUMATISM

The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus

(2010) Hyejung Jung et al.   ARTHRITIS AND RHEUMATISM

Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients

(2010) Michelle Petri   Current Rheumatology Reports

Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health study

(2009) A. Elisabeth Hak et al.   ARTHRITIS AND RHEUMATISM

Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus

(2009) A Becker-Merok et al.   LUPUS

Factors Associated with Arterial Vascular Events in PROFILE: A Multiethnic Lupus Cohort

(2009) AM Bertoli et al.   LUPUS

Annual incidence and standardized incidence ratio of cerebrovascular accidents in patients with systemic lupus erythematosus

(2009) CC Mok et al.   SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

(2009) Johanna Gustafsson et al.   ARTHRITIS RESEARCH & THERAPY

General Cardiovascular Risk Profile for Use in Primary Care

(2008) Ralph B. D’Agostino et al.   CIRCULATION